TLR9 and acute myeloid leukemia: This study showed that AML patients with favorable or intermediate risk per the European LeukemiaNet (ELN) classification were more likely to carry the rs187084 C allele in the TLR9 gene, which was less frequent in those with unfavorable prognosis, suggesting a protective role against high‐risk AML.